Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazuhiko Irinoda is active.

Publication


Featured researches published by Kazuhiko Irinoda.


Plasmid | 2002

Characterization of pKU701, a 2.5-kb plasmid, in a Japanese Helicobacter pylori isolate.

Yoshio Hosaka; Ryoichi Okamoto; Kazuhiko Irinoda; Satoru Kaieda; Wasaburo Koizumi; Katunori Saigenji; Matsuhisa Inoue

A cryptic plasmid of Helicobacter pylori, pKU701 (accession number AB078638), was isolated and the complete nucleotide sequence was determined. No drug resistance properties were mediated by pKU701. The 2454b pKU701 sequence, which had a 38% content of G-C residues, generated one polypeptide from a single open reading frame (ORF1). Extensive sequence homology was evident between pKU701 and ORF1 of H. pylori plasmid pHPO100 (repA, 88.8% identity) as well as ORF3 of plasmid pHPS1 (repB, 80.2% identity), but pKU701 showed only 46.3% homology with ORF1 of plasmid pHPK255 (repA). Tandem direct repeats of a 33-bp segment were found in pKU701 outside ORF1, but there were no inverted repeat ends such as those found in typical insertion sequences. The ability of drug resistance plasmids to replicate in H. pylori is probably limited, so chromosomal mutation may be a more likely cause of resistance.


International Journal of Antimicrobial Agents | 2003

Investigation of methicillin-resistant Staphylococcus aureus showing reduced vancomycin susceptibility isolated from a patient with infective endocarditis

Yoko Takayama; Hideaki Hanaki; Kazuhiko Irinoda; Hideya Kokubun; Kazunari Yoshida; Keisuke Sunakawa

A patient with infective endocarditis (IE) caused by methicillin-resistant Staphylococcus aureus (MRSA) was treated with vancomycin (VAN). VAN was ineffective, although therapeutic drug monitoring (TDM) indicated that the recommended trough level was maintained. Five MRSA isolates obtained at various times were analyzed to determine the minimum inhibitory concentration (MIC) and were subjected to population analysis, simulation analysis pulsed-field gel electrophoresis (PFGE). MRSA susceptible to VAN was isolated before and during the early stage of treatment, while an MRSA strain showing reduced VAN MIC was isolated during treatment. Simulation analysis indicated that the viable bacterial count only decreased to 10(-3) to 10(-4) cells after 72 h of incubation. The five MRSA strains isolated at various times were identical by PFGE.


Journal of Clinical Microbiology | 2005

Use of the restriction enzyme EcoRI for pulsed-field gel electrophoretic analysis of Helicobacter pylori.

Yoshio Hosaka; Kazuhiko Irinoda; Ryuichi Nakano; Satosi Tanabe; Wasaburo Koizumi; Katunori Saigenji; Matsuhisa Inoue

ABSTRACT Pulsed-field gel electrophoretic (PFGE) analysis of Helicobacter pylori isolates is not commonly employed because of the inability to compare the typing with other typing systems. We adapted the PFGE analysis for H. pylori by using EcoRI and slightly modified our laboratory methods to improve the typing of isolates (typeability was 97%).


Journal of Clinical Microbiology | 2000

Pulsed-Field Gel Electrophoresis Analysis of Nasopharyngeal Flora in Children Attending a Day Care Center

Hisakazu Yano; Mitsuko Suetake; Akio Kuga; Kazuhiko Irinoda; Ryoichi Okamoto; Toshimitsu Kobayashi; Matsuhisa Inoue


The Journal of Antibiotics | 1987

Azinomycins A and B, new antitumor antibiotics. III. Antitumor activity.

Seiji Ishizeki; Mari Ohtsuka; Kazuhiko Irinoda; Kenichi Kukita; Katsuhiko Nagaoka; Toshiaki Nakashima


Antimicrobial Agents and Chemotherapy | 2002

Antagonism between Aminoglycosides and β-Lactams in a Methicillin-Resistant Staphylococcus aureus Isolate Involves Induction of an Aminoglycoside-Modifying Enzyme

Takashi Ida; Ryoichi Okamoto; Masato Nonoyama; Kazuhiko Irinoda; Mizuyo Kurazono; Matsuhisa Inoue


The Journal of Antibiotics | 1999

Presence of genes for β-lactamases of two different classes on a single plasmid from a clinical isolate of Serratia marcescens

Hisakazu Yano; Akio Kuga; Kazuhiko Irinoda; Ryoichi Okamoto; Toshimitsu Kobayashi; Matsuhisa Inoue


Journal of Infection and Chemotherapy | 2003

Pretreatment of Pseudomonas aeruginosa with a sub-MIC of imipenem enhances bactericidal activity of neutrophils

Takeshi Sasahara; Yoshinori Satoh; Tomoko Sekiguchi; Kaoruko Suzuki; Kazuhiko Irinoda; Yoko Takayama; Ayako Sakamoto; Hidero Kitasato; Ryoichi Okamoto; Matsuhisa Inoue


The Journal of Antibiotics | 2000

Antibacterial activity of 16 antibiotics against Helicobacter pylori

Yoshio Hosaka; Kazuhiko Irinoda; Ryuichi Nakano; Kitasato H; Ryouichi Okamoto; Katunori Saigenji; Matsuhisa Inoue


The Journal of Antibiotics | 2002

Helicobacter pylori May Survive Ampicillin Treatment in the Remnant Stomach.

Yoshio Hosaka; Ryoichi Okamoto; Kazuhiko Irinoda; Satoru Kaieda; Wasaburo Koizumi; Katunori Saigenji; Matsuhisa Inoue

Collaboration


Dive into the Kazuhiko Irinoda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge